# TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

> **NCT02018055** · PHASE4 · COMPLETED · sponsor: **The Catholic University of Korea** · enrollment: 2590 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Aspirin+Ticagrelor
- **DRUG:** Aspirin+Clopidogrel

## Key facts

- **NCT ID:** NCT02018055
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-14
- **Primary completion:** 2021-01-21
- **Final completion:** 2021-01-21
- **Target enrollment:** 2590 (ACTUAL)
- **Last updated:** 2021-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018055, "TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02018055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*